Lunar revenues climb, but profit falls
Bone densitometry firm Lunar’s effort to grow revenues by targeting the physician office market is experiencing success. The Madison, WI, company enjoyed a 22% rise in revenues for its third quarter (end-September). Lower profit margins associated
Bone densitometry firm Lunars effort to grow revenues by targeting the physician office market is experiencing success. The Madison, WI, company enjoyed a 22% rise in revenues for its third quarter (end-September). Lower profit margins associated with the initiative resulted in declining net income for the firm, however.
For the quarter, Lunar recorded revenues of $22.8 million, compared with $18.7 million in the third quarter of 1997. Lunars net income for the third quarter of 1998 was $1.2 million, compared with $2 million in the third quarter of 1997. Lunars profit for the most recent quarter was also affected by a $580,000 charge for the settlement of patent litigation.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
